Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047846
Filing Date
2024-11-14
Accepted
2024-11-14 15:25:15
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocgn-20240930.htm   iXBRL 10-Q 1030103
2 EX-31.1 ocgn-20240930x10qxex311.htm EX-31.1 10082
3 EX-31.2 ocgn-20240930x10qxex312.htm EX-31.2 9802
4 EX-32.1 ocgn-20240930x10qxex321.htm EX-32.1 7330
10 GRAPHIC ocgn-20240930_g1.jpg GRAPHIC 27940
  Complete submission text file 0001628280-24-047846.txt   5973541

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20240930.xsd EX-101.SCH 36033
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocgn-20240930_cal.xml EX-101.CAL 59549
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocgn-20240930_def.xml EX-101.DEF 193168
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20240930_lab.xml EX-101.LAB 562641
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20240930_pre.xml EX-101.PRE 394202
72 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20240930_htm.xml XML 720431
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36751 | Film No.: 241460951
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)